Cited by 779Menopause: Health Impacts and TreatmentsEstrogen and related hormone effectsHormonal and reproductive studies

The DOI matches its Crossref record; 42 of the 42 references it cites were found in a registry or an index.

Vascular Effects of Early versus Late Postmenopausal Treatment with Estradiol

Open access

Hodis, Howard N., Mack, Wendy J., Henderson, Victor W., Shoupe, Donna, Budoff, Matthew J., Hwang-Levine, Juliana, Li, Yanjie, Feng, Mei, Dustin, Laurie, Kono, Naoko, Stanczyk, Frank Z., Selzer, Robert H., Azen, Stanley P.·2016·New England Journal of Medicine

DOI 10.1056/nejmoa1505241PMC PMC4921205

Open this paper in CoChat — free account Open PDF

Abstract

BACKGROUND: Data suggest that estrogen-containing hormone therapy is associated with beneficial effects with regard to cardiovascular disease when the therapy is initiated temporally close to menopause but not when it is initiated later. However, the hypothesis that the cardiovascular effects of postmenopausal hormone therapy vary with the timing of therapy initiation (the hormone-timing hypothesis) has not been tested. METHODS: A total of 643 healthy postmenopausal women were stratified according to time since menopause (<6 years [early postmenopause] or ≥10 years [late postmenopause]) and were randomly assigned to receive either oral 17β-estradiol (1 mg per day, plus progesterone [45 mg] vaginal gel administered sequentially [i.e., once daily for 10 days of each 30-day cycle] for women with a uterus) or placebo (plus sequential placebo vaginal gel for women with a uterus). The primary outcome was the rate of change in carotid-artery intima-media thickness (CIMT), which was measured every 6 months. Secondary outcomes included an assessment of coronary atherosclerosis by cardiac computed tomography (CT), which was performed when participants completed the randomly assigned regimen. RESULTS: After a median of 5 years, the effect of estradiol, with or without progesterone, on CIMT progression differed between the early and late postmenopause strata (P=0.007 for the interaction). Among women who were less than 6 years past menopause at the time of randomization, the mean CIMT increased by 0.0078 mm per year in the placebo group versus 0.0044 mm per year in the estradiol group (P=0.008). Among women who were 10 or more years past menopause at the time of randomization, the rates of CIMT progression in the placebo and estradiol groups were similar (0.0088 and 0.0100 mm per year, respectively; P=0.29). CT measures of coronary-artery calcium, total stenosis, and plaque did not differ significantly between the placebo group and the estradiol group in either postmenopause stratum. CONCLUSIONS: Oral estradiol therapy was associated with less progression of subclinical atherosclerosis (measured as CIMT) than was placebo when therapy was initiated within 6 years after menopause but not when it was initiated 10 or more years after menopause. Estradiol had no significant effect on cardiac CT measures of atherosclerosis in either postmenopause stratum. (Funded by the National Institute on Aging, National Institutes of Health; ELITE ClinicalTrials.gov number, NCT00114517.).

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1056/nejmoa1505241

Cites

42 of 42 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

A Simple Sequentially Rejective Multiple Test Procedure
(1979) · Scandinavian Journal of Statistics · doi:10.2307/4615733 · Cited by 21,526
A reporting system on patients evaluated for coronary artery disease. Report of the Ad Hoc Committee for Grading of Coronary Artery Disease, Council on Cardiovascular Surgery, American Heart Association
Wg, A., Edwards, J., Frye, R., Gg, G., Gott, V. L., Griffith, L., McGoon, D. C., Murphy, M., & Roe, B. B. (1975) · Circulation · doi:10.1161/01.cir.51.4.5 · Cited by 3,255
Diagnostic Performance of 64-Multidetector Row Coronary Computed Tomographic Angiography for Evaluation of Coronary Artery Stenosis in Individuals Without Known Coronary Artery Disease
Budoff, M. J., Dowe, D. A., Jollis, J. G., Gitter, M. J., Sutherland, J., Halamert, E., Scherer, M. D., Bellinger, R. L., Martin, A., Benton, R., et al. (2008) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2008.07.031 · Cited by 2,121
Menopausal hormone therapy and health outcomes during the intervention and extended poststopping phases of the Women’s Health Initiative randomized trials
Manson, J. E., Chlebowski, R. T., Stefanick, M. L., Aragaki, A. K., Rossouw, J. E., Prentice, R. L., Anderson, G., Howard, B. V., Thomson, C. A., LaCroix, A. Z., et al. (2013) · JAMA · doi:10.1001/jama.2013.278040 · Cited by 1,650
Effects of Estrogen Replacement on the Progression of Coronary-Artery Atherosclerosis
Herrington, D. M., Reboussin, D. M., Brosnihan, K. B., Sharp, P. C., Shumaker, S. A., Snyder, T. E., Furberg, C. D., Kowalchuk, G. J., Stuckey, T. D., Rogers, W. J., et al. (2000) · New England Journal of Medicine · doi:10.1056/nejm200008243430801 · Cited by 1,242
The Role of Carotid Arterial Intima-Media Thickness in Predicting Clinical Coronary Events
Hodis, H. N., Mack, W. J., LaBree, L., Selzer, R. H., Liu, C.-R., Liu, C.-H., & Azen, S. P. (1998) · Annals of Internal Medicine · doi:10.7326/0003-4819-128-4-199802150-00002 · Cited by 1,217
Calcified Coronary Artery Plaque Measurement with Cardiac CT in Population-based Studies: Standardized Protocol of Multi-Ethnic Study of Atherosclerosis (MESA) and Coronary Artery Risk Development in Young Adults (CARDIA) Study
Carr, J. J., Nelson, J. C., Wong, N. D., McNitt‐Gray, M. F., Arad, Y., Jacobs, D. R., Sidney, S., Bild, D. E., Williams, O. D., & Detrano, R. (2005) · Radiology · doi:10.1148/radiol.2341040439 · Cited by 855
Effect of hormone replacement therapy on cardiovascular events in recently postmenopausal women: randomised trial
Schierbeck, L. L., Rejnmark, L., Tofteng, C. L., Stilgren, L. S., Eiken, P., Mosekilde, L., Køber, L., & Jensen, J. B. (2012) · BMJ · doi:10.1136/bmj.e6409 · Cited by 753
Estrogen Therapy and Coronary-Artery Calcification
Manson, J. E., Allison, M. A., Rossouw, J. E., Carr, J. J., Langer, R. D., Hsia, J., Kuller, L. H., Cochrane, B. B., Hunt, J. R., Ludlam, S. E., et al. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa071513 · Cited by 711
Estrogen Improves Endothelium-Dependent, Flow-Mediated Vasodilation in Postmenopausal Women
Lieberman, E. H., Gerhard, M. D., Uehata, A., Walsh, B. W., Selwyn, A. P., Ganz, P., Yeung, A. C., & Creager, M. A. (1994) · Annals of Internal Medicine · doi:10.7326/0003-4819-121-12-199412150-00005 · Cited by 701

Show all 42 references

Research works printed but not linked: 2

Holm S, 1979, Scand J Stat, 6, 65
Boardman HM, 2015, Cochrane Database Syst Rev, CD002229

Sorted by citations

Osteoporosis
Compston, J. E., McClung, M. R., & Leslie, W. D. (2019) · The Lancet · doi:10.1016/s0140-6736(18)32112-3 · Cited by 2,449
The Lancet women and cardiovascular disease Commission: reducing the global burden by 2030
Vogel, B., Mónica Acevedo, B., Appelman, Y., Merz, C. N. B., Chieffo, A., Figtree, G. A., Guerrero, M. E., Kunadian, V., Lam, C. S. P., Maas, A. H. E. M., et al. (2021) · The Lancet · doi:10.1016/s0140-6736(21)00684-x · Cited by 1,587
Menopause Transition and Cardiovascular Disease Risk: Implications for Timing of Early Prevention: A Scientific Statement From the American Heart Association
El Khoudary, S. R., Aggarwal, B., Beckie, T. M., Hodis, H. N., Johnson, A. E., Langer, R. D., Limacher, M. C., Manson, J. E., Stefanick, M. L., Allison, M. A., et al. (2020) · Circulation · doi:10.1161/cir.0000000000000912 · Cited by 1,219
The 2017 hormone therapy position statement of The North American Menopause Society
The North American Menopause Society (2017) · Menopause The Journal of The North American Menopause Society · doi:10.1097/gme.0000000000000921 · Cited by 1,042
The 2022 hormone therapy position statement of The North American Menopause Society
(2022) · Menopause · doi:10.1097/gme.0000000000002028 · Cited by 977
The Menopause Transition: Signs, Symptoms, and Management Options
Santoro, N. F., Roeca, C. M., Peters, B. A., & Neal-Perry, G. S. (2020) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgaa764 · Cited by 774
Menopausal Hormone Therapy and Long-term All-Cause and Cause-Specific Mortality
Manson, J. E., Aragaki, A. K., Rossouw, J. E., Anderson, G. L., Prentice, R. L., LaCroix, A. Z., Chlebowski, R. T., Howard, B. V., Thomson, C. A., Margolis, K. L., et al. (2017) · JAMA · doi:10.1001/jama.2017.11217 · Cited by 663
Long term hormone therapy for perimenopausal and postmenopausal women
Farquhar, C. M., Marjoribanks, J., Lethaby, A. E., Suckling, J. A., & Okonkwo, Q. L. (2005) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd004143.pub2 · Cited by 587
Role of Estrogens in the Regulation of Liver Lipid Metabolism
Palmisano, B. T., Zhu, L., & Stafford, J. M. (2017) · Advances in experimental medicine and biology · doi:10.1007/978-3-319-70178-3_12 · Cited by 577
“The Early versus Late Intervention Trial with Estradiol (ELITE) study was designed to test the timing hypothesis (Hodis et al. 2016).”
Background
Sex differences in lipid and lipoprotein metabolism
Palmisano, B. T., Zhu, L., Eckel, R. H., & Stafford, J. M. (2018) · Molecular Metabolism · doi:10.1016/j.molmet.2018.05.008 · Cited by 551
“The timing hypothesis was tested in the Early versus Late Intervention Trial with Estradiol (ELITE) study, which randomized postmenopausal women to placebo or oral estradiol plus vaginal progesterone for 10 days per cycle [100].”
Method
Hormone-replacement therapy: current thinking
Lobo, R. A. (2016) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2016.164 · Cited by 526
Age and Sex Are Critical Factors in Ischemic Stroke Pathology
Roy-O’Reilly, M. A., & McCullough, L. D. (2018) · Endocrinology · doi:10.1210/en.2018-00465 · Cited by 498
Carotid Intima-Media Thickness Progression as Surrogate Marker for Cardiovascular Risk
Willeit, P., Tschiderer, L., Allara, E., Reuber, K., Seekircher, L., Gao, L., Liao, X., Lonn, E., Gerstein, H. C., Yusuf, S., et al. (2020) · Circulation · doi:10.1161/circulationaha.120.046361 · Cited by 476
Long-term hormone therapy for perimenopausal and postmenopausal women
Marjoribanks, J., Farquhar, C. M., Roberts, H., Lethaby, A. E., & Lee, J. (2017) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd004143.pub5 · Cited by 447
Ovarian hormones and obesity
Leeners, B., Geary, N., Tobler, P. N., & Asarian, L. (2017) · Human Reproduction Update · doi:10.1093/humupd/dmw045 · Cited by 407
Summary of Updated Recommendations for Primary Prevention of Cardiovascular Disease in Women
Cho, L., Davis, M. B., Elgendy, I. Y., Epps, K., Lindley, K. J., Mehta, P. K., Michos, E. D., Minissian, M., Pepine, C. J., Vaccarino, V., et al. (2020) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2020.03.060 · Cited by 363
“However, these findings have not been seen consistently in other trials (120,121).”
Result
Cardiovascular health after menopause transition, pregnancy disorders, and other gynaecologic conditions: a consensus document from European cardiologists, gynaecologists, and endocrinologists
Maas, A. H. E. M., Rosano, G. M. C., Cífková, R., Chieffo, A., van Dijken, D., Hamoda, H., Kunadian, V., Laan, E. T. M., Lambrinoudaki, I. V., Maclaran, K., et al. (2020) · European Heart Journal · doi:10.1093/eurheartj/ehaa1044 · Cited by 382
Sex Hormones and Sex Chromosomes Cause Sex Differences in the Development of Cardiovascular Diseases
Arnold, A. P., Cassis, L. A., Eghbali, M., Reue, K., & Sandberg, K. L. (2017) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.116.307301 · Cited by 339
Pregnancy and Reproductive Risk Factors for Cardiovascular Disease in Women
O’Kelly, A. C., Michos, E. D., SHUFELT, C. L., Vermunt, J. V., Minissian, M., Quesada, O., Smith, G. N., Rich-Edwards, J. W., Garovic, V. D., Khoudary, S. R. E., et al. (2022) · Circulation Research · doi:10.1161/circresaha.121.319895 · Cited by 358
Management of Menopausal Symptoms
Crandall, C. J., Mehta, J. M., & Manson, J. E. (2023) · JAMA · doi:10.1001/jama.2022.24140 · Cited by 360
Sex and gender in cardiovascular medicine: presentation and outcomes of acute coronary syndrome
Haider, A., Bengs, S., Luu, J., Osto, E., Siller-Matula, J. M., Muka, T., & Gebhard, C. (2019) · European Heart Journal · doi:10.1093/eurheartj/ehz898 · Cited by 322
The Controversial History of Hormone Replacement Therapy
Cagnacci, A., & Venier, M. (2019) · Medicina · doi:10.3390/medicina55090602 · Cited by 300
“More recent randomized trials have tested the timing hypothesis, the Early versus Late Intervention with Estradiol (ELITE) study [70] and the Kronos Early Estrogen Prevention Study (KEEPS) [71], and have reported a protective effect of HRT in young women close to menopause.”
Background
Hormonal Treatments for Major Depressive Disorder: State of the Art
Dwyer, J. B., Aftab, A., Radhakrishnan, R., Widge, A., Rodriguez, C. I., Carpenter, L. L., Nemeroff, C. B., McDonald, W. M., Kalin, N. H., & APA Council of Research Task Force on Novel Biomarkers and Treatments (2020) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2020.19080848 · Cited by 252
Body composition and cardiometabolic health across the menopause transition
Marlatt, K. L., Pitynski, D., Gavin, K. M., Moreau, K. L., Melanson, E. L., Santoro, N. F., & Kohrt, W. M. (2021) · Obesity · doi:10.1002/oby.23289 · Cited by 261
Premature Ovarian Insufficiency - an update on recent advances in understanding and management
Torrealday, S., Kodaman, P. H., & Pal, L. (2017) · F1000Research · doi:10.12688/f1000research.11948.1 · Cited by 224
Rethinking Menopausal Hormone Therapy: For Whom, What, When, and How Long?
Cho, L., Kaunitz, A. M., Faubion, S. S., Hayes, S. N., Lau, E. S., Pristera, N., Scott, N. S., Shifren, J. L., SHUFELT, C. L., Stuenkel, C. A., et al. (2023) · Circulation · doi:10.1161/circulationaha.122.061559 · Cited by 242
American Association of Clinical Endocrinologists and American College of Endocrinology Position Statement on Menopause–2017 Update
Cobin, R. H., & Goodman, N. F. (2017) · Endocrine Practice · doi:10.4158/ep171828.ps · Cited by 210
Menopausal hormone therapy and women’s health: An umbrella review
Zhang, G.-Q., Chen, J.-L., Luo, Y., Mathur, M. B., Anagnostis, P. G., Nurmatov, U. B., Talibov, M., Zhang, J., Hawrylowicz, C. M., Lumsden, M. A., et al. (2021) · PLoS Medicine · doi:10.1371/journal.pmed.1003731 · Cited by 228
“…caused additional events in women (mean baseline age � 60 years) with established CHD. ELITE (Early versus Late Intervention Trial with Estradiol) [134], the first trial specifically designed to test the timing hypothesis, found that oral estradiol reduced the progression of subclinical…”
Background
Estrogen Receptor Signaling in Breast Cancer
Miziak, P. A., Baran, M. T., Błaszczak, E., Przybyszewska-Podstawka, A., Kałafut, J., Smok-Kalwat, J., Dmoszyńska‐Graniczka, M., Kiełbus, M., & Stepulak, A. (2023) · Cancers · doi:10.3390/cancers15194689 · Cited by 228
“The effect of estrogens on the cardiovascular system may be protective, as shown by several studies, including large-scale clinical trials [27–29], but have also been associated with the risk of coronary heart disease [30].”
Background
The Role of Estrogen Receptors and Their Signaling across Psychiatric Disorders
Hwang, W. J., Lee, T. Y., Kim, N. S., & Kwon, J. S. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms22010373 · Cited by 222
“It was revealed in a study that the early treatment of ERT has a cardioprotective effect, whereas the same treatment when treated 10 years after menopause exerted risk-enhancing effects [173].”
Background
Sex Differences in Myocardial and Vascular Aging
Ji, H., Kwan, A. C., Chen, M. T., Ouyang, D., Ebinger, J. E., Bell, S. P., Niiranen, T., Bello, N. A., & Cheng, S. C. (2022) · Circulation Research · doi:10.1161/circresaha.121.319902 · Cited by 210
Menopausal hormone therapy for the management of osteoporosis
Gosset, A., Pouillès, J.-M., & Trémollieres, F. (2021) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2021.101551 · Cited by 193
The British Menopause Society & Women’s Health Concern 2020 recommendations on hormone replacement therapy in menopausal women
Hamoda, H., Panay, N., Pedder, H., Arya, R., & Savvas, M. (2020) · Post Reproductive Health · doi:10.1177/2053369120957514 · Cited by 192
“The ‘Early versus Late Intervention Trial with Estradiol’ (ELITE) by Hodis et al. (2016) reported on the cardiovascular effects of HRT in relation to the timing of initiation of treatment.”
Background
Sex and Gender Driven Modifiers of Alzheimer’s: The Role for Estrogenic Control Across Age, Race, Medical, and Lifestyle Risks
Rahman, A., Jackson, H. C., Hristov, H., Isaacson, R., Saif, N., Shetty, T., Etingin, O. R., Henchcliffe, C., Brinton, R. D., & Mosconi, L. (2019) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2019.00315 · Cited by 204
Aromatase: Contributions to Physiology and Disease in Women and Men
Blakemore, J. K., & Naftolin, F. N. (2016) · Physiology · doi:10.1152/physiol.00054.2015 · Cited by 193
Menopausal Hormone Replacement Therapy and Reduction of All-Cause Mortality and Cardiovascular Disease
Hodis, H. N., & Mack, W. J. (2022) · The Cancer Journal · doi:10.1097/ppo.0000000000000591 · Cited by 211
Risks, Benefits, and Treatment Modalities of Menopausal Hormone Therapy: Current Concepts
Mehta, J. M., Kling, J. M., & Manson, J. E. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.564781 · Cited by 206
“Similarly, ELITE found that oral estradiol did not impact verbal memory, executive functions, or global cognition in women who started HT 6 years within menopause or 10 years or more after menopause (77).”
BackgroundInfluential
The Kronos Early Estrogen Prevention Study (KEEPS): what have we learned?
Miller, V. M., Naftolin, F. N., Asthana, S., Black, D. M., Brinton, E. A., Budoff, M. J., Cedars, M. I., Dowling, N. M., Gleason, C. E., Hodis, H. N., et al. (2019) · Menopause The Journal of The North American Menopause Society · doi:10.1097/gme.0000000000001326 · Cited by 188
Management of menopause: a view towards prevention
Lobo, R. A., & Gompel, A. (2022) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(21)00269-2 · Cited by 183
Treating menopause — MHT and beyond
Davis, S. R., & Baber, R. (2022) · Nature Reviews Endocrinology · doi:10.1038/s41574-022-00685-4 · Cited by 189
Hormone Therapy in Menopause: Concepts, Controversies, and Approach to Treatment
Flores, V. A., Pal, L., & Manson, J. E. (2021) · Endocrine Reviews · doi:10.1210/endrev/bnab011 · Cited by 174
Lifelong Gender Gap in Risk of Incident Myocardial Infarction
Albrektsen, G., Heuch, I., Løchen, M., Thelle, D. S., Wilsgaard, T., Njølstad, I., & Bønaa, K. H. (2016) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2016.5451 · Cited by 173
Sex-Specific Physiology and Cardiovascular Disease
SHUFELT, C. L., Pacheco, C., Tweet, M. S., & Miller, V. M. (2018) · Advances in experimental medicine and biology · doi:10.1007/978-3-319-77932-4_27 · Cited by 177
The 2017 hormone therapy position statement of The North American Menopause Society
(2018) · Menopause The Journal of The North American Menopause Society · doi:10.1097/gme.0000000000001241 · Cited by 172
Hormone Therapy for the Primary Prevention of Chronic Conditions in Postmenopausal Women
Gartlehner, G., Patel, S. V., Feltner, C., Weber, R. P., de Long, R., Mullican, K., Boland, E., Lux, L. J., & Viswanathan, M. (2017) · JAMA · doi:10.1001/jama.2017.16952 · Cited by 166
Menopause
Minkin, M. J. (2019) · Obstetrics and Gynecology Clinics of North America · doi:10.1016/j.ogc.2019.04.008 · Cited by 164
Hormone replacement therapy – Current recommendations
Vigneswaran, K., & Hamoda, H. (2022) · Best Practice & Research Clinical Obstetrics & Gynaecology · doi:10.1016/j.bpobgyn.2021.12.001 · Cited by 151
Is there a role for menopausal hormone therapy in the management of postmenopausal osteoporosis?
Rozenberg, S., Al-Daghri, N., Aubertin-Leheudre, M., Brandi, M.-L., Cano, A., Collins, P., Cooper, C., Genazzani, A. R., Hillard, T., Kanis, J. A., et al. (2020) · Osteoporosis International · doi:10.1007/s00198-020-05497-8 · Cited by 149
Stroke in women — from evidence to inequalities
the Women Initiative for Stroke in Europe (WISE) group, Cordonnier, C., Sprigg, N., Sandset, E. C., Pavlovic, A. M., Sunnerhagen, K. S., Caso, V., & Christensen, H. (2017) · Nature Reviews Neurology · doi:10.1038/nrneurol.2017.95 · Cited by 155
The route of administration, timing, duration and dose of postmenopausal hormone therapy and cardiovascular outcomes in women: a systematic review
Oliver‐Williams, C., Glišić, M., Shahzad, S., Brown, E., Baena, C. P., Chadni, M., Chowdhury, R., Franco, O. H., & Muka, T. (2018) · Human Reproduction Update · doi:10.1093/humupd/dmy039 · Cited by 155
Back to the future: Hormone replacement therapy as part of a prevention strategy for women at the onset of menopause
Lobo, R. A., Pickar, J. H., Stevenson, J. C., Mack, W. J., & Hodis, H. N. (2016) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2016.10.005 · Cited by 152
“The Early versus Late intervention Trial with Estradiol (ELITE) was a RCT specifically designed to test the HRT timing hypothesis in relation to atherosclerosis progression in postmenopausal women [53].”
BackgroundMethod
Sex differences in risk factors for vascular contributions to cognitive impairment & dementia
Gannon, O. J., Robison, L. S., Custozzo, A. J., & Zuloaga, K. L. (2018) · Neurochemistry International · doi:10.1016/j.neuint.2018.11.014 · Cited by 146
Association of Age at Menopause and Hormone Therapy Use With Tau and β-Amyloid Positron Emission Tomography
Coughlan, G., Betthauser, T. J., Boyle, R. T., Koscik, R. L., Klinger, H. M., Chibnik, L. B., Jonaitis, E. M., Yau, W. W., Wenzel, A., Christian, B. T., et al. (2023) · JAMA Neurology · doi:10.1001/jamaneurol.2023.0455 · Cited by 136
Menopause and cardiovascular disease
Newson, L. R. (2018) · Post Reproductive Health · doi:10.1177/2053369117749675 · Cited by 131
“In the Early versus Late Intervention Trial with Estradiol, postmenopausal women free from cardiovascular disease were stratified according to time since menopause and were randomly assigned to receive either 17b-estradiol plus micronised progesterone vaginal gel or placebo over a median of 5 years.(39) Compared with…”
The 2020 Menopausal Hormone Therapy Guidelines
Lee, S. R., Cho, M. K., Cho, Y. J., Chun, S., Hong, S.-H., Hwang, K. R., Jeon, G., Joo, J. K., Kim, S. K., Lee, D. O., et al. (2020) · Journal of Menopausal Medicine · doi:10.6118/jmm.20000 · Cited by 136
Vitamin D, Calcium, Parathyroid Hormone, and Sex Steroids in Bone Health and Effects of Aging
Bhattarai, H. K., Shrestha, S., Rokka, K., & Shakya, R. (2020) · Journal of Osteoporosis · doi:10.1155/2020/9324505 · Cited by 140
Menopause and the Skin: Old Favorites and New Innovations in Cosmeceuticals for Estrogen-Deficient Skin
Lephart, E. D., & Naftolin, F. N. (2020) · Dermatology and Therapy · doi:10.1007/s13555-020-00468-7 · Cited by 146
Sex differences in neuroinflammation and neuroprotection in ischemic stroke
Spychala, M. S., Honarpisheh, P., & McCullough, L. D. (2017) · Journal of Neuroscience Research · doi:10.1002/jnr.23962 · Cited by 127
“…was associated with less progression of subclinical atherosclerosis, measured as carotid-artery intima-media thickness (CIMT) as compared to placebo when therapy was initiated within six years after menopause but not when it was initiated 10 or more years after menopause (Hodis et al., 2016).”
BackgroundResult
Hormone replacement therapy in young women with surgical primary ovarian insufficiency
Sarrel, P. M., Sullivan, S. D., & Nelson, L. M. (2016) · Fertility and Sterility · doi:10.1016/j.fertnstert.2016.09.018 · Cited by 129
Cardiometabolic Effects of Testosterone in Transmen and Estrogen Plus Cyproterone Acetate in Transwomen
van Velzen, D. M., Paldino, A., Klaver, M., Nota, N. M., Defreyne, J., Hovingh, G. K., Thijs, A., Şimşek, S., T'Sjoen, G. G., & den Heijer, M. (2019) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2018-02138 · Cited by 124
The interplay between diabetes mellitus and menopause: clinical implications
Lambrinoudaki, I. V., Paschou, S. Α., Armeni, E., & Goulis, D. G. (2022) · Nature Reviews Endocrinology · doi:10.1038/s41574-022-00708-0 · Cited by 131
Understanding the variation in exercise responses to guide personalized physical activity prescriptions
Noone, J., Mucinski, J. M., DeLany, J. P., Sparks, L. M., & Goodpaster, B. H. (2024) · Cell Metabolism · doi:10.1016/j.cmet.2023.12.025 · Cited by 128
Age at Menarche and Risk of Cardiovascular Disease Outcomes: Findings From the National Heart Lung and Blood Institute‐Sponsored Women's Ischemia Syndrome Evaluation
Lee, J., Cook‐Wiens, G., Johnson, B. D., Braunstein, G. D., Berga, S. L., Stanczyk, F. Z., Pepine, C. J., Merz, C. N. B., & SHUFELT, C. L. (2019) · Journal of the American Heart Association · doi:10.1161/jaha.119.012406 · Cited by 122
Association of Age at Menopause With Incident Heart Failure: A Prospective Cohort Study and Meta‐Analysis
Appiah, D., Schreiner, P. J., Demerath, E. W., Loehr, L. R., Chang, P. P., & Folsom, A. R. (2016) · Journal of the American Heart Association · doi:10.1161/jaha.116.003769 · Cited by 126
“Although a few trials among recently menopausal women show slower progressions of carotid artery intima–media thickness in women taking estradiol,(47) others show no effect of estradiol or other hormone therapies on vascular endothelial function,(48) carotid artery intima–media thickness,(49) or coronary artery calciu…”
Result
Endogenous and Exogenous Estrogen Exposures: How Women’s Reproductive Health Can Drive Brain Aging and Inform Alzheimer’s Prevention
Jett, S., Malviya, N., Schelbaum, E., Jang, G., Jahan, E., Clancy, K., Hristov, H., Pahlajani, S. S., Niotis, K., Loeb‐Zeitlin, S., et al. (2022) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2022.831807 · Cited by 124
What the Women's Health Initiative has taught us about menopausal hormone therapy
Chester, R. C., Kling, J. M., & Manson, J. E. (2018) · Clinical Cardiology · doi:10.1002/clc.22891 · Cited by 116
Hormone replacement therapy – where are we now?
Langer, R. D., Hodis, H. N., Løbo, R. A., & Allison, M. (2021) · Climacteric · doi:10.1080/13697137.2020.1851183 · Cited by 118
Hormone therapy regimens for managing the menopause and premature ovarian insufficiency
Armeni, E., Paschou, S. Α., Goulis, D. G., & Lambrinoudaki, I. V. (2021) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2021.101561 · Cited by 116
Menopause-associated risk of cardiovascular disease
Anagnostis, P. G., Lambrinoudaki, I. V., Stevenson, J. C., & Goulis, D. G. (2022) · Endocrine Connections · doi:10.1530/ec-21-0537 · Cited by 126
Systematic review and meta-analysis of the effects of menopause hormone therapy on risk of Alzheimer’s disease and dementia
Nerattini, M., Jett, S., Andy, C., Carlton, C., Zarate, C., Boneu, C., Battista, M., Pahlajani, S. S., Loeb‐Zeitlin, S., Havryulik, Y., et al. (2023) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2023.1260427 · Cited by 123
Menopausal Hormone Therapy and Cardiovascular Disease: The Role of Formulation, Dose, and Route of Delivery
SHUFELT, C. L., & Manson, J. E. (2021) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgab042 · Cited by 124
MECHANISMS IN ENDOCRINOLOGY: Aging and anti-aging: a Combo-Endocrinology overview
Diamanti‐Kandarakis, E., Dattilo, M., Μacut, D., Duntas, L. H., Gonos, E. S., Goulis, D. G., Kanaka‐Gantenbein, C., Καπετάνου, Μ., Koukkou, E. G., Lambrinoudaki, I. V., et al. (2017) · European Journal of Endocrinology · doi:10.1530/eje-16-1061 · Cited by 105
Women's brain aging: Effects of sex‐hormone exposure, pregnancies, and genetic risk for Alzheimer's disease
de Lange, A. G., Barth, C., Kaufmann, T., Maximov, I. I., van der Meer, D., Agartz, I., & Westlye, L. T. (2020) · Human Brain Mapping · doi:10.1002/hbm.25180 · Cited by 98
“close to menopause (MacLennan et al., 2006; Gibbs & Gabor, 2003; Hodis et al., 2016), we further tested whether age at HRT initiation, both alone and in relation to age at menopause, was associated with”
Background
Hormone Therapy in Menopause
Paciuc, J. (2020) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-38474-6_6 · Cited by 105
Estrogen and the Vascular Endothelium: The Unanswered Questions
SenthilKumar, G., Katunaric, B., Bordas-Murphy, H., Sarvaideo, J. L., & Freed, J. K. (2023) · Endocrinology · doi:10.1210/endocr/bqad079 · Cited by 99
The impact of micronized progesterone on breast cancer risk: a systematic review
Stute, P., Wildt, L., & Neulen, J. (2018) · Climacteric · doi:10.1080/13697137.2017.1421925 · Cited by 96
Hormone therapy in the postmenopausal years: considering benefits and risks in clinical practice
Genazzani, A. R., Monteleone, P., Giannini, A., & Simoncini, T. (2021) · Human Reproduction Update · doi:10.1093/humupd/dmab026 · Cited by 113
Female hormonal factors and the development of anti-citrullinated protein antibodies in women at risk of rheumatoid arthritis
Alpizar-Rodriguez, D., Mueller, R. B., Möller, B., Dudler, J., Ciurea, A., Zufferey, P., Kyburz, D., Walker, U. A., von Mühlenen, I., Roux‐Lombard, P., et al. (2017) · Rheumatology · doi:10.1093/rheumatology/kex239 · Cited by 94
Sex differences in blood pressure regulation and hypertension: renal, hemodynamic, and hormonal mechanisms
Drury, E. R., Wu, J., Gigliotti, J. C., & Le, T. H. (2023) · Physiological Reviews · doi:10.1152/physrev.00041.2022 · Cited by 103
Cardiovascular Risk Following Fertility Therapy
Dayan, N., Filion, K. B., Okano, M., Kilmartin, C., Reinblatt, S., Landry, T., Basso, O., & Udell, J. A. (2017) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2017.07.753 · Cited by 94
Estrogen and cardiovascular disease
Gersh, F. L., O’Keefe, J. H., Elagizi, A., Lavie, C. J., & Laukkanen, J. A. (2024) · Progress in Cardiovascular Diseases · doi:10.1016/j.pcad.2024.01.015 · Cited by 93
Hormones and Aging: An Endocrine Society Scientific Statement
Cappola, A. R., Auchus, R. J., Fuleihan, G. E., Handelsman, D. J., Kalyani, R. R., McClung, M. R., Stuenkel, C. A., Thorner, M. O., & Verbalis, J. G. (2023) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgad225 · Cited by 108
“Several RCTs designed specifically to examine the CHD effects of the timing hypothesis yielded inconsistent results (117, 134-136) (Table 2).”
BackgroundResultInfluential
Maintaining postreproductive health: A care pathway from the European Menopause and Andropause Society (EMAS)
Armeni, E., Lambrinoudaki, I. V., Ceauşu, I., Depypere, H. T., Mueck, A. O., Pérez-López, F. R., van der Schouw, Y. T., Senturk, L. M., Simoncini, T., Stevenson, J. C., et al. (2016) · Maturitas · doi:10.1016/j.maturitas.2016.04.013 · Cited by 88
Vasomotor Symptoms During Menopause: A Practical Guide on Current Treatments and Future Perspectives
Khan, S. J., Kapoor, E., Faubion, S. S., & Kling, J. M. (2023) · International Journal of Women s Health · doi:10.2147/ijwh.s365808 · Cited by 98
“atherosclerosis with HT use, showed that women who started HT early in menopause (within 36 months or less than 6 years from FMP, respectively) may not only avoid conferred CVD risks of HT but also have slower progression of atherosclerosis compared to women who utilized placebo.(35,36) In 2015, a Cochrane review of r…”
The menopausal transition period and cardiovascular risk
Mehta, J. M., & Manson, J. E. (2023) · Nature Reviews Cardiology · doi:10.1038/s41569-023-00926-7 · Cited by 99
“…of starting oral oestradiol (1 mg per day) early before the onset of menopause ( 6 years) versus later (≥10 years after menopause) and found that starting oral oestradiol early was associated with less progression of subclinical atherosclerosis (measured as cIMT) compared with placebo 104,105 .”
Sex-specific eNOS activity and function in human endothelial cells
Cattaneo, M. G., Vanetti, C., Decimo, I., Chio, M. D., Martano, G., Garrone, G., Bifari, F., & Vicentini, L. M. (2017) · Scientific Reports · doi:10.1038/s41598-017-10139-x · Cited by 88
The evidence base for HRT: what can we believe?
Langer, R. D. (2017) · Climacteric · doi:10.1080/13697137.2017.1280251 · Cited by 86
“The Early versus Late Intervention with Estrogen (ELITE) trial 28 enrolled women in two distinct age ranges to test the ‘ timing hypothesis ’ that emerged from the WHI and the earlier Heart and Estrogen Replacement Study (HERS) 29 .”
Background
Association of endogenous sex hormone levels with coronary artery calcium progression among post-menopausal women in the Multi-Ethnic Study of Atherosclerosis (MESA)
Subramanya, V., Zhao, D., Ouyang, P., Ying, W., Vaidya, D. M., Ndumele, C. E., Heckbert, S. R., Budoff, M. J., Post, W. S., & Michos, E. D. (2018) · Journal of cardiovascular computed tomography · doi:10.1016/j.jcct.2018.09.010 · Cited by 85
Lipoprotein(a) in atherosclerosis: from pathophysiology to clinical relevance and treatment options
Likozar, A. R., Zavrtanik, M., & Šebeštjen, M. (2020) · Annals of Medicine · doi:10.1080/07853890.2020.1775287 · Cited by 91
“changes in carotid artery intima media thickness, coronary artery calcium) [112,113].”
Background
The Role of 17β-Estradiol and Estrogen Receptors in Regulation of Ca2+ Channels and Mitochondrial Function in Cardiomyocytes
Mahmoodzadeh, S., & Dworatzek, E. (2019) · Frontiers in Endocrinology · doi:10.3389/fendo.2019.00310 · Cited by 90
“late menopause period (19, 23, 24), indicating the importance of the time point of HRT-application.”
Background
Estrogen deficiency accelerates postmenopausal atherosclerosis by inducing endothelial cell ferroptosis through inhibiting NRF2 / GPX4 pathway
Lv, Y., Zhang, S., Weng, X., Huang, J., Zhao, H., Dai, X., Bai, X., Bao, X., Zhao, C., Zeng, M., et al. (2023) · The FASEB Journal · doi:10.1096/fj.202300083r · Cited by 84
Cardiovascular risk assessment in women – an update
Collins, P. D., Webb, C. M., de Villiers, T. J., Stevenson, J. C., Panay, N., & Baber, R. (2016) · Climacteric · doi:10.1080/13697137.2016.1198574 · Cited by 82
Cardiovascular health and the menopausal woman: the role of estrogen and when to begin and end hormone treatment
Naftolin, F. N., Friedenthal, J., Nachtigall, R. H., & Nachtigall, L. E. (2019) · F1000Research · doi:10.12688/f1000research.15548.1 · Cited by 82
Cardiovascular Risk in Women With Premature Ovarian Insufficiency Compared to Premenopausal Women at Middle Age
Daan, N. M. P., Muka, T., Koster, M. P. H., van Lennep, J. E. R., Lambalk, C. B., Laven, J. S. E., Fauser, C. G. K. M., Meun, C., de Rijke, Y. B., Boersma, E. H., et al. (2016) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2016-1141 · Cited by 86
Sex differences in the genetic and molecular mechanisms of coronary artery disease
Sakkers, T. R., Mokrý, M., Civelek, M., Erdmann, J., Pasterkamp, G., Benavente, E. D., & den Ruijter, H. M. (2023) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2023.117279 · Cited by 81
Estrogen deficiency in the menopause and the role of hormone therapy: integrating the findings of basic science research with clinical trials
Yang, J. L., Hodara, E., Sriprasert, I., Shoupe, D., & Stanczyk, F. Z. (2024) · Menopause The Journal of The North American Menopause Society · doi:10.1097/gme.0000000000002407 · Cited by 80
Importance of sex and gender in ischaemic stroke and carotid atherosclerotic disease
Gasbarrino, K., Iorio, D. D., & Daskalopoulou, S. S. (2021) · European Heart Journal · doi:10.1093/eurheartj/ehab756 · Cited by 84
A systematic review and meta-regression analysis to examine the ‘timing hypothesis’ of hormone replacement therapy on mortality, coronary heart disease, and stroke
Nudy, M. S., Chinchilli, V. M., & Foy, A. (2019) · IJC Heart & Vasculature · doi:10.1016/j.ijcha.2019.01.001 · Cited by 80
The History of Estrogen Therapy
Kohn, G. E., Rodriguez, K. M., Hotaling, J. M., & Pastuszak, A. W. (2019) · Sexual Medicine Reviews · doi:10.1016/j.sxmr.2019.03.006 · Cited by 76
“This study specifically looked at atherosclerosis with estradiol therapy with or without progesterone and found that progression of carotid-artery intima-media thickness was lower in the estradiol group, in comparison with placebo, for women who were <6 years post-menopause but not those who were 10 years post-menopau…”
Is Hormone Replacement Therapy a Risk Factor or a Therapeutic Option for Alzheimer’s Disease?
Mills, Z., Faull, R. L. M., & Kwakowsky, A. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24043205 · Cited by 82

Authors: Hodis, H. N., Mack, W. J., Henderson, V. W., Shoupe, D., Budoff, M. J., Hwang-Levine, J., Li, Y., Feng, M., Dustin, L., Kono, N., Stanczyk, F. Z., Selzer, R. H., & Azen, S. P.
Affiliations: General Department of Preventive Medicine (VN)
Stanford University (US)
University of California, Los Angeles (US)
ORCID: Mack, Wendy J.
Henderson, Victor W.
Budoff, Matthew J.
Li, Yanjie
Stanczyk, Frank Z.
Venue: New England Journal of Medicine
Publisher: Massachusetts Medical Society
Published: 2016-03-31
Volume: 374
Issue: 13
Pages: 1221-1231
ISSN: 0028-4793 (ISSN-L)
1533-4406
DOI: 10.1056/nejmoa1505241
PMC: PMC4921205
OpenAlex: W2330799317
Cited by: 779
References: 42
Citations by year: 2026: 95 · 2025: 67 · 2024: 54 · 2023: 72 · 2022: 80 · 2021: 83 · 2020: 65 · 2019: 77 · 2018: 73 · 2017: 74 · 2016: 36
FWCI: 86.77
Type: journal article
Language: en
Open access: bronze
doi.org
Locations: New England Journal of Medicine (publishedVersion)
PubMed (publishedVersion)
Europe PMC (PubMed Central) (acceptedVersion)
PubMed Central (acceptedVersion)
eScholarship (California Digital Library) (submittedVersion)
Funders: National Institute on Aging (R01-AG024154-S2, R01AG-024154-01-05, R01AG024154, R01AG-024154-06-08)
Topics: Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Menopause: Health Impacts and Treatments
Life Sciences › Biochemistry, Genetics and Molecular Biology › Endocrinology › Estrogen and related hormone effects
Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hormonal and reproductive studies
Keywords: hormone replacement therapy, estradiol, timing of hormone therapy initiation, carotid intima-media thickness, subclinical atherosclerosis, coronary artery calcium, coronary artery stenosis, coronary plaque, cardiovascular risk, menopause, progesterone, oral estradiol, cardiac CT, cardiovascular disease prevention, postmenopausal women
MeSH terms: Administration, Intravaginal, Administration, Oral, Carotid Arteries, Coronary Artery Disease, Drug Administration Schedule, Estradiol, Female, Humans, Middle Aged, Progesterone, Estrogen Replacement Therapy, Linear Models, Postmenopause, Disease Progression, Atherosclerosis, Carotid Intima-Media Thickness

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Vascular Effects of Early versus Late Postmenopausal Treatment with Estradiol

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks